Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroblastoma and dendritic cell function.

Richard E Redlinger1, Robbie B Mailliard, Edward M Barksdale

  • 1Department of Surgery, University of Pittsburgh School of Medicine, Division of Pediatric Surgery, Children's Hospital of Pittsburgh, Pittsburgh, PA 15213-2583, USA.

Seminars in Pediatric Surgery
|February 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Type-1 inflammatory imprinting and programmed responsiveness to CD40L enhance Siglec-1-dependent HIV-1 trans-infection by dendritic cells.

Frontiers in immunology·2026
Same author

Type 1-polarized DC immunotherapeutic contains heterogeneous populations with IL-12p70 production restricted to a rare subset.

bioRxiv : the preprint server for biology·2026
Same author

Induction of HIV-Specific T Cell Responses Using αDC1 Pulsed With Conserved HIV-1 Peptides.

Journal of immunology research·2026
Same author

HIV causes global B cell dysregulation and restricts HBV-specific B cell development in an incident HBV cohort.

The Journal of clinical investigation·2026
Same author

Return to Sport After Revision Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis.

The American journal of sports medicine·2026
Same author

Pancreatic Cancer Organoids Recapitulate Chemotherapy Response and Identify a Potent Cytotoxic T-Cell Population.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025

Neuroblastoma immune evasion hinders treatment. Dendritic cells (DCs) are key to initiating anti-tumor immunity, but neuroblastoma can disrupt DC function, necessitating novel DC-based vaccine strategies for regression.

Area of Science:

  • Pediatric Surgical Oncology
  • Cancer Immunology
  • Immunotherapy

Background:

  • Neuroblastoma is a common childhood extracranial solid tumor with limited effective conventional therapies.
  • Spontaneous regression in some neuroblastomas suggests a role for immune-mediated mechanisms.
  • Dendritic cells (DCs) are critical for initiating cellular immune responses to cancer.

Purpose of the Study:

  • To review the role of dendritic cells (DCs) in initiating and coordinating immune responses against cancer.
  • To discuss how neuroblastoma disrupts DC maturation and function.
  • To explore current vaccine strategies utilizing DCs for neuroblastoma regression.

Main Methods:

  • Literature review on dendritic cell function in pediatric solid tumors, specifically neuroblastoma.

Related Experiment Videos

  • Analysis of mechanisms by which neuroblastoma inhibits DC maturation and function.
  • Examination of current dendritic cell-based vaccine strategies for neuroblastoma.

    • Main Results:

    • Dendritic cells (DCs) play a sentinel role in initiating anti-tumor immune responses.
    • Neuroblastoma can evade immune detection by inducing DC dysregulation.
    • Novel vaccine strategies aim to leverage DC function to promote neuroblastoma regression.

    Conclusions:

    • Understanding DC-neuroblastoma interactions is crucial for developing effective immunotherapies.
    • Targeting DC pathways offers a promising avenue for treating aggressive neuroblastoma.
    • Dendritic cell-based vaccines represent a novel therapeutic approach for pediatric cancer.